Bristol-Myers's policy quest splits industry
In a move that has split the politically powerful U.S. drug industry, Bristol-Myers Squibb Co. is bankrolling an intensive behind the scenes lobbying effort to protect its biggest selling drug from
In a move that has split the politically powerful U.S. drug industry, Bristol-Myers Squibb Co. is bankrolling an intensive behind the scenes lobbying effort to protect its biggest selling drug from